EAN News

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024.

Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK.

The EAN welcomes the European Medicine Agency’s decision to approve lecanemab for the treatment of early Alzheimer's disease, which provides a much-needed treatment opportunity for this devastating condition.

It is with profound sadness that we announce the loss of Prof. Giancarlo Comi, former president of the European Neurological Society (ENS), a leading figure in the neurological community, and an inspiring example to neurologists and researchers worldwide.

The EAN is pleased to announce the establishment of the European Journal of Neurology Jes Olesen Award, recognising exceptional research in the field of neurology and related specialties.

The EAN is involved in the session 'Headache burden: the professionals’ and patients’ perspective' at the European Headache Congress on 4 December.

Our successful 2024 Advocacy Training participants talk about their experience and how the training has equipped them to champion brain health!

RRFS study provides insight into how junior neurologists across Europe perceive their access to training and certification in neurosonology, underlining the need for a more standardised approach.

As part of the EAN's mission to strengthen connections with its full institutional members, we interviewed leaders from various national neurological societies across Europe and beyond.

Young neurologists are invited to test and prove their preparation in next year's European Board Exam in Neurology, which will be held online on 9-10 May (oral) and 16 May (written) 2025.

Interested in strengthening your advocacy skills to help raise the voice of brain health? Find out more about the EAN Advocacy Training programme, taking place March-June 2025.

Dr Giacomo Sferruzza, the new EAN Resident & Research Fellow Section (RRFS) Chair, gives an overview of the RRFS Office team, and their aims and priorities for the term ahead.

We are excited to announce the publication of our Sustainability Report 2024, which highlights the steps we have taken to integrate sustainable practices throughout our operations and supply chains.

Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.